Health app on smartphone Digitalmedicine aims to improve patients' health by giving them ways toalter behavior, tools to cope with disease or reminders to takemedicine.

Sanofi is joining other big pharmaceutical companies inexpanding beyond pills and injections into a new frontier oftech-based treatments that doctors canprescribe.

Working with partner Happify Health, the French drugmaker isstudying a potential digital therapy for patients with depressionand multiple sclerosis. That follows the launch last year of asimilar type of prescription treatment from Novartis AG and PearTherapeutics Inc. aimed at substance abuse, the first of its kindto win U.S. Food and Drug Administration approval.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.